Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.

Hamers FF, Rumeau-Pichon C.

BMC Pediatr. 2012 Jun 8;12:60. doi: 10.1186/1471-2431-12-60.

2.

Newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) in the UK.

Goddard P.

J Fam Health Care. 2004;14(4):90-2. Review.

PMID:
15453442
3.

Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review.

Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S.

Health Technol Assess. 2004 Mar;8(12):iii, 1-121. Review.

4.

The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update.

Grosse SD, Khoury MJ, Greene CL, Crider KS, Pollitt RJ.

Genet Med. 2006 Apr;8(4):205-12. Review.

PMID:
16617240
5.

Neonatal screening for inborn errors of metabolism: cost, yield and outcome.

Pollitt RJ, Green A, McCabe CJ, Booth A, Cooper NJ, Leonard JV, Nicholl J, Nicholson P, Tunaley JR, Virdi NK.

Health Technol Assess. 1997;1(7):i-iv, 1-202. Review.

6.

Economics of tandem mass spectrometry screening of neonatal inherited disorders.

Pandor A, Eastham J, Chilcott J, Paisley S, Beverley C.

Int J Technol Assess Health Care. 2006 Summer;22(3):321-6. Review.

PMID:
16984060
7.

Newborn screening for medium chain acyl CoA dehydrogenase deficiency.

Leonard JV, Dezateux C.

Arch Dis Child. 2009 Mar;94(3):235-8. doi: 10.1136/adc.2007.134957. Epub 2008 Oct 6. Review.

PMID:
18838415
8.

Extended newborn screening: an update for the general paediatrician.

Coman D, Bhattacharya K.

J Paediatr Child Health. 2012 Feb;48(2):E68-72. doi: 10.1111/j.1440-1754.2011.02199.x. Epub 2011 Oct 21. Review.

PMID:
22017206
9.

Newborn screening for inborn errors of metabolism: a systematic review.

Seymour CA, Thomason MJ, Chalmers RA, Addison GM, Bain MD, Cockburn F, Littlejohns P, Lord J, Wilcox AH.

Health Technol Assess. 1997;1(11):i-iv, 1-95. Review.

10.

Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective.

Rhead WJ.

J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):370-7. Review.

PMID:
16763904
11.

Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome.

Dezateux C.

Eur J Pediatr. 2003 Dec;162 Suppl 1:S25-8. Epub 2003 Nov 20. Review.

PMID:
14628139
12.

Newborn screening.

Wilcken B, Wiley V.

Pathology. 2008 Feb;40(2):104-15. doi: 10.1080/00313020701813743. Review.

PMID:
18203033
13.

Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases.

Moorthie S, Cameron L, Sagoo GS, Bonham JR, Burton H.

J Inherit Metab Dis. 2014 Nov;37(6):889-98. doi: 10.1007/s10545-014-9729-0. Epub 2014 Jul 15. Review.

PMID:
25022222
14.

[Medium-chain acyl-CoA-dehydrogenase (MCAD) deficiency: French consensus for neonatal screening, diagnosis, and management].

Feillet F, Ogier H, Cheillan D, Aquaviva C, Labarthe F, Baruteau J, Chabrol B, de Lonlay P, Valayanopoulos V, Garnotel R, Dobbelaere D, Briand G, Jeannesson E, Vassault A, Vianey-Saban C; SFEIM (Société française pour l’étude des erreurs innées du métabolisme).

Arch Pediatr. 2012 Feb;19(2):184-93. doi: 10.1016/j.arcped.2011.10.025. Epub 2012 Jan 12. French.

PMID:
22244319
15.

Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.

Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C.

Health Technol Assess. 2005 Nov;9(44):1-152, iii-iv. Review.

16.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

17.
18.

Data required for the evaluation of newborn screening programmes.

Liebl B, Nennstiel-Ratzel U, Roscher A, von Kries R.

Eur J Pediatr. 2003 Dec;162 Suppl 1:S57-61. Epub 2003 Nov 13. Review.

PMID:
14615887
19.

Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.

Bishop Hubbard H.

Policy Polit Nurs Pract. 2007 Aug;8(3):201-9. doi: 10.1177/1527154407303498. Review.

PMID:
18178927
20.

The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.

Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A, O'Hagan A, Moore D.

Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. Review.

Supplemental Content

Support Center